PERFUSIX Trademark

Trademark Overview


On Monday, November 29, 2021, a trademark application was filed for PERFUSIX with the United States Patent and Trademark Office. The USPTO has given the PERFUSIX trademark a serial number of 97147018. The federal status of this trademark filing is REGISTERED as of Tuesday, February 13, 2024. This trademark is owned by LIMIS Development B.V.. The PERFUSIX trademark is filed in the Medical Instrument Products category with the following description:

Medical instruments, namely, perfusion imaging for minimally invasive namely gastrointestinal surgery and open surgery, namely open heart surgery and plastic surgery; Medical imaging apparatus; Apparatus for imaging of perfusion, namely, blood flow visualization; Sensor apparatus for medical use in monitoring the vital signs of patients; Medical apparatus for monitoring vital signs; Medical instruments for perfusion imaging in minimally invasive and open surgery incorporating lasers; Laser machining tools, namely, Laser Speckle Contrast Imaging instrument for perfusion imaging for medical use
perfusix

General Information


Serial Number97147018
Word MarkPERFUSIX
Filing DateMonday, November 29, 2021
Status700 - REGISTERED
Status DateTuesday, February 13, 2024
Registration Number7301967
Registration DateTuesday, February 13, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 31, 2023

Trademark Statements


Goods and ServicesMedical instruments, namely, perfusion imaging for minimally invasive namely gastrointestinal surgery and open surgery, namely open heart surgery and plastic surgery; Medical imaging apparatus; Apparatus for imaging of perfusion, namely, blood flow visualization; Sensor apparatus for medical use in monitoring the vital signs of patients; Medical apparatus for monitoring vital signs; Medical instruments for perfusion imaging in minimally invasive and open surgery incorporating lasers; Laser machining tools, namely, Laser Speckle Contrast Imaging instrument for perfusion imaging for medical use

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, December 2, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLIMIS Development B.V.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLeeuwarden 8934
NL

Party NameLIMIS Development B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLeeuwarden 8934
NL

Party NameLIMIS Development B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLeeuwarden 8934
NL

Trademark Events


Event DateEvent Description
Tuesday, February 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 13, 2024REGISTERED-PRINCIPAL REGISTER
Thursday, January 11, 20241(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, January 11, 2024NOTICE OF ALLOWANCE CANCELLED
Tuesday, December 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 31, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 26, 2023ASSIGNED TO LIE
Sunday, May 7, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 6, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 6, 2023LETTER OF SUSPENSION E-MAILED
Monday, March 6, 2023SUSPENSION LETTER WRITTEN
Wednesday, February 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 16, 2022NON-FINAL ACTION E-MAILED
Friday, September 16, 2022NON-FINAL ACTION WRITTEN
Wednesday, September 7, 2022ASSIGNED TO EXAMINER
Thursday, December 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 2, 2021NEW APPLICATION ENTERED